I

interlinked

lightning_bolt Market Research

Interlinked Company Profile



Background



Overview

Interlinked is a medical device company established in 2016, dedicated to enhancing patient safety and reducing medical errors in healthcare. The company focuses on developing innovative solutions for intravenous (IV) therapy, aiming to improve patient outcomes and operational efficiency in healthcare settings.

Mission and Vision

Interlinked's mission is to advance patient safety and reduce medical errors by providing needs-based, smart, and innovative solutions for the global healthcare industry. The company's vision is to improve people's lives through the development of high-quality medical devices that address unmet healthcare needs.

Primary Area of Focus

The company's primary focus is on IV therapy, specifically developing technologies that enhance the safety and efficiency of IV lines. Their flagship product, ReLink, is an advanced breakaway connector designed to prevent patient injuries, reduce hazardous drug spills, and minimize complications and costs associated with IV catheter use.

Industry Significance

Interlinked operates within the medical device industry, contributing to the advancement of patient safety and the reduction of medical errors. The company's innovations, particularly in IV therapy, have the potential to significantly impact healthcare practices by improving patient outcomes and operational efficiency.

Key Strategic Focus



Core Objectives

Interlinked aims to develop and commercialize medical devices that address critical safety concerns in healthcare, with a particular emphasis on IV therapy. The company seeks to enhance patient safety, reduce medical errors, and improve the overall quality of healthcare delivery.

Specific Areas of Specialization

The company specializes in the development of safety connectors for IV lines, focusing on creating solutions that prevent patient injuries and reduce complications associated with IV catheter use. Their expertise lies in designing and manufacturing medical devices that address specific safety challenges in healthcare settings.

Key Technologies Utilized

Interlinked employs advanced engineering and medical device technologies to develop its products. The company's proprietary technology, ReLink, is a breakaway connector designed to prevent patient injuries and hazardous drug spills, showcasing their commitment to innovative solutions in medical device design.

Primary Markets or Conditions Targeted

The primary market targeted by Interlinked includes healthcare facilities that utilize IV therapy, such as hospitals, clinics, and home care settings. The company's products are designed to address safety concerns associated with IV catheter use, aiming to improve patient outcomes and reduce healthcare costs.

Financials and Funding



Funding History

Interlinked has secured funding through various grants and awards to support the development and commercialization of its products. Notably, the company has received support from the European Union's Horizon 2020 research and innovation programme, including the EIC Accelerator grant and the Fast Track to Innovation grant. Additionally, Interlinked has been co-funded by the Eurostars-2 Joint Programme under Horizon 2020.

Total Funds Raised

Specific details regarding the total funds raised by Interlinked are not publicly disclosed. However, the company has demonstrated its ability to attract significant funding through competitive grants and awards, indicating strong investor confidence in its mission and products.

Notable Investors

While specific investor names are not publicly disclosed, Interlinked's funding sources include prestigious programs such as the European Union's Horizon 2020 research and innovation programme, which supports high-impact research and innovation projects across Europe.

Intended Utilization of Capital

The capital raised by Interlinked is primarily intended for the development, manufacturing, and commercialization of its medical devices, particularly the ReLink connector. The funding supports research and development activities, regulatory approvals, production scaling, and market expansion efforts to enhance patient safety in healthcare settings.

Pipeline Development



Key Pipeline Candidates

Interlinked's key pipeline candidate is the ReLink connector, an advanced breakaway connector for IV lines designed to prevent patient injuries and hazardous drug spills. This product represents the company's commitment to addressing critical safety concerns in healthcare.

Stages of Clinical Trials or Product Development

Specific details regarding the stages of clinical trials or product development for ReLink are not publicly disclosed. However, the company has received significant support from European Union research and innovation programmes, indicating progress in product development and readiness for commercialization.

Target Conditions

The ReLink connector is designed to address safety concerns associated with IV catheter use, aiming to prevent patient injuries, reduce hazardous drug spills, and minimize complications and costs related to IV therapy.

Relevant Timelines for Anticipated Milestones

While specific timelines for anticipated milestones are not publicly disclosed, Interlinked's receipt of grants and awards suggests active development and progress toward bringing ReLink to market. The company's focus on commercialization indicates a strategic roadmap aimed at achieving significant milestones in the near future.

Technological Platform and Innovation



Proprietary Technologies

Interlinked's proprietary technology, ReLink, is an advanced breakaway connector for IV lines. This device is engineered to prevent patient injuries, reduce hazardous drug spills, and minimize complications and costs associated with IV catheter use. ReLink exemplifies the company's dedication to innovative solutions in medical device design.

Significant Scientific Methods

Interlinked employs advanced engineering and medical device design methodologies to develop its products. The company's focus on creating safety connectors for IV lines reflects a commitment to high standards in safety, reliability, and ease of use.
Browse SuperAGI Directories
agi_contact_icon
People Search
agi_company_icon
Company Search
AGI Platform For Work Accelerate business growth, improve customer experience & dramatically increase productivity with Agentic AI